Rheumatoid Arthritis News

The FDA approved rituximab-arrx for multiple indications.

Drug maker Gilead Sciences has announced it will no longer pursue FDA approval for its janus kinase inhibitor filgotinib in the treatment of rheumatoid arthritis, according to a company press release.

Reddit and other online forums allow patients with rheumatoid arthritis to anonymously share mental health experiences they likely would not otherwise share with others, according to findings published in BMC Rheumatology.

There were approximately 1.3 billion cases of musculoskeletal disorders worldwide in 2017, leading to 121,300 deaths and 138.7 million disability adjusted life years, according to findings published in Arthritis & Rheumatology.

On the evening of Nov. 19, the FDA issued an emergency use authorization for the rheumatoid arthritis drug baricitinib in combination with remdesivir for patients hospitalized with suspected or confirmed COVID-19.

The FDA issued an emergency use authorization for baricitinib in combination with remdesivir for patients hospitalized with suspected or confirmed COVID-19, according to a press release.

The emergence of novel therapies over the last decade has turned the treatment of rheumatoid arthritis upside down.

Among patients with rheumatoid arthritis, herpes zoster is more common in those treated with upadacitinib than with adalimumab plus methotrexate or with methotrexate alone, according to a speaker at ACR Convergence 2020.

Patients with autoimmune rheumatic diseases are less likely to avoid an office visit or laboratory tests due to COVID-19 and were more likely to have telehealth visits, according to a speaker at ACR Convergence 2020.

In patients with rheumatoid arthritis who achieve remission with combination therapy and then withdraw either etanercept or methotrexate, monotherapy with the former is superior to the latter for remission maintenance, noted a speaker here.